Research field (1)：
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (2)：
2022 - 2024 ミトコンドリア置換技術を用いた、がん細胞におけるmtDNAの影響の解明
2021 - 2024 固形癌に対するCPC-1 CAR-T療法の実用化に向けたex vivo 安全性/有効性評価法の確立
Papers (32)：
Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, Masaki Yamamoto, Miki Nagao, Satoshi Morita, Takako E. Nakajima, et al. Author Correction: Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination. Nature Aging. 2023. 3. 6
Norihide Jo, Yu Hidaka, Osamu Kikuchi, Masaru Fukahori, Takeshi Sawada, Masahiko Aoki, Masaki Yamamoto, Miki Nagao, Satoshi Morita, Takako E Nakajima, et al. Delayed CD4 +T-cell response in older adults is associated with reduced immunogenicity and reactogenicity after COVID-19 mRNA vaccination. The Journal of Immunology. 2023. 210. 1_Supplement
Takeshi Sawada, Tomonori Yaguchi, Yuko Sakai, Chinatsu Suzuki, Kenji Morii, Masahiko Aoki, Masaru Fukahori, Satoshi Serada, Tetsuji Naka, Jun K. Yamashita, et al. Abstract 907: Evaluation of the anti-GPC1 scFv-Fc fusion protein as a detection tool of GPC1 expression in human cancers. Cancer Research. 2023. 83. 7_Supplement
Ryo Negishi, Hitomi Yamakawa, Takeru Kobayashi, Mayuko Horikawa, Tatsu Shimoyama, Fumiaki Koizumi, Takeshi Sawada, Keisuke Oboki, Yasushi Omuro, Chikako Funasaka, et al. Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer. Communications biology. 2022. 5. 1. 20-20
Takayasu Kurata, Kazuhiko Nakagawa, Miyako Satouchi, Takashi Seto, Takeshi Sawada, Shirong Han, Masae Homma, Kazuo Noguchi, Naoyuki Nogami. Phase 1 study of pembrolizumab plus chemotherapy as first-line treatment in Japanese patients with advanced NSCLC. Cancer Treatment and Research Communications. 2021. 29. 100458-100458
Yuta Ishiyama, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yusuke Kanemasa, Yasushi Omuro, Yoshiharu Maeda. Study of Pneumocystis Pneumonia of Trimethoprim/Sulfamethoxazole in NHL patients receiving R-CHOP regimen. ANNALS OF ONCOLOGY. 2016. 27
Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1-positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042
(ESMO selected BEST Abstract plenary session 2019)
Immune system pathway activation for prediction of the response to neoadjuvant chemotherapy in triple negative breast cancer
(2017)
Mutational analysis of primary tumors and single circulating tumor cells captured by a novel dielectrophoretic microwell array system in metastatic lung cancer, oral cancer and breast cancer patients
(The 28th EORTC-NCI-AACR symposium 2016)
Developing Circulating Tumor Cell Detection Systems
(The 1st Circulating Tumor Cell Forum 2016 2016)
Identification of a novel compound, MO2455, that induces poly(ADP-ribose) (PAR) accumulation and inhibits the growth of cancer cells in vitro and in vivo
(American Association for Cancer Research Annual Meeting 2016 2016)
